In-vitro and in-silico investigation of anti-dengue phytocompounds from Bergenia ciliata (Haw.) Sternb. via inhibition of host protein ER-α-glucosidase
- 28 April 2025
- journal article
- research article
- Published by Springer Nature in Proceedings of the Indian National Science Academy
- Vol. 92 (2) , 615-627
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studiesJournal of Molecular Modeling, 2022
- Bergenia ciliata: A comprehensive review of its traditional uses, phytochemistry, pharmacology and safetyBiomedicine & Pharmacotherapy, 2018
- Molecular docking and simulation studies of Phyllanthus amarus phytocompounds against structural and nucleocapsid proteins of white spot syndrome virus3 Biotech, 2017
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trialThe Lancet Infectious Diseases, 2014
- Natural products: A continuing source of novel drug leadsBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against α-glucosidase and α-amylase linked to type 2 diabetesFood Chemistry, 2012
- SwissParam: A fast force field generation tool for small organic moleculesJournal of Computational Chemistry, 2011
- Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivoAntiviral Research, 2011
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009